Product Information
BACLOFEN 5 MG/5 ML SOLUTION is a generic product labeled by Advagen Pharma Ltd., priced at $1.0702 per ML under NDC 72888010324. Its NADAC has been published 73 times since Mar 12, 2025.
FDA first approved this application on Dec 6, 2024. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Advagen Pharma Ltd.NDC
72888010324
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BACLOFENApproval Type
Generic (ANDA)
FDA Application
ANDA214445FDA Approved
12/6/2024
TE Code
AA
On Market Since
12/6/2024
Pharmacological Classes
Price Statistics
The NADAC for BACLOFEN 5 MG/5 ML SOLUTION has been published 73 times since Mar 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0702 per ML |
|---|---|
| All-time high | $1.1757 (Jun 10, 2026) |
| All-time low | $1.0638 (Mar 12, 2025) |
| 52-week high | $1.1757 |
| 52-week low | $1.0702 |
| Median price | $1.1030 |
| Average price | $1.1038 |
| Largest weekly change | -3.2% (Jun 17, 2026) |
| Weeks tracked | 73 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Baclofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BACLOFEN 5 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 5 MG/5 ML SOLUTION, manufactured by Advagen Pharma Ltd., is $1.0702 per ML (NDC 72888010324), effective Sep 30, 2026.
How has the price of BACLOFEN 5 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for BACLOFEN 5 MG/5 ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 73 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for BACLOFEN 5 MG/5 ML SOLUTION?
Since Mar 12, 2025, the NADAC for BACLOFEN 5 MG/5 ML SOLUTION has ranged from a low of $1.0638 (Mar 12, 2025) to a high of $1.1757 (Jun 10, 2026), with a median of $1.1030 per ML.
Are there cheaper alternatives to BACLOFEN 5 MG/5 ML SOLUTION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BACLOFEN 5 MG/5 ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures BACLOFEN 5 MG/5 ML SOLUTION?
BACLOFEN 5 MG/5 ML SOLUTION (NDC 72888010324) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.